MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41598-024-52526-1

Медицинская библиотека · Scientific reports · 2024

Efficacy of golimumab in patients with refractory non-infectious panuveitis.

Tungsattayathitthan Usanee, Tesavibul Nattaporn, Choopong Pitipol, Treeratsakulchai Chaipat, Ngathaweesuk Yaninsiri, Sanphan Wilawan, Boonsopon Sutasinee

СтатьяПеревод пока не подготовлен

Аннотация

This study investigated the efficacy of golimumab in the management of refractory non-infectious panuveitis. Nineteen patients (38 eyes; mean age, 31 years) were retrospectively reviewed between June 2016 and June 2022. All patients had bilateral eye involvement and Behçet's disease was the most common diagnosis (57.9%). Compared to the period before golimumab treatment, the rate of uveitis relapses after golimumab treatment significantly decreased from 1.73 to 0.62 events per person-years (incidence ratio 0.33, 95% confidence interval 0.19-0.57, P < 0.001). After golimumab therapy, 12 patients (63.2%) were able to reduce the number or dosage of immunosuppressive drugs, and the median dosage of systemic corticosteroids was reduced from 15.0 to 7.5 mg/d (P = 0.013) compared to baseline. The median logMAR visual acuity improved from 0.9 at baseline to 0.6 at the last visit (P = 0.006). Golimumab demonstrated efficacy against refractory non-infectious panuveitis in terms of a corticosteroid-sparing effect and reduced the rate of uveitis relapses to approximately one-third.

Для цитирования: Tungsattayathitthan Usanee, Tesavibul Nattaporn, Choopong Pitipol, Treeratsakulchai Chaipat, Ngathaweesuk Yaninsiri, Sanphan Wilawan, Boonsopon Sutasinee. Efficacy of golimumab in patients with refractory non-infectious panuveitis.. Scientific reports. 2024. DOI: 10.1038/s41598-024-52526-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.